Table 3.
Placebo (n=19) | Inulin (n=19) | p | ||||
---|---|---|---|---|---|---|
Baseline | After | Baseline | After | Baseline | After | |
SBP (mmHg) | ||||||
≤ 120 | 5 | 6 | 2 | 2 | 0.071 | 0.251 |
120.1-130 | 8 | 5 | 4 | 7 | ||
130.1-140 | 0 | 2 | 5 | 5 | ||
≥140.1 | 6 | 6 | 8 | 5 | ||
| ||||||
DBP (mmHg) | ||||||
< 89 | 17 | 15 | 18 | 18 | 0.999 | 0.340 |
> 90 | 2 | 4 | 1 | 1 | ||
| ||||||
MAP (mmHg) | ||||||
< 102 | 12 | 17 | 13 | 19 | 0.999 | 0.486 |
>102.1 | 7 | 2 | 6 | 0 | ||
| ||||||
HR (BPM) | ||||||
< 100 | 19 | 18 | 18 | 19 | 0.999 | 0.486 |
> 100.1 | 0 | 1 | 1 | 0 | ||
| ||||||
BMI (kg/m2) | ||||||
Underweight | 1 | 2 | 1 | 0 | 0.628 | 0.418 |
Normal | 6 | 6 | 4 | 5 | ||
Overweight | 8 | 9 | 7 | 7 | ||
Obese Class I | 3 | 2 | 6 | 4 | ||
Obese Class II | 1 | 0 | 0 | 1 | ||
Obese Class III | 0 | 0 | 1 | 1 | ||
| ||||||
BFP (%) | ||||||
Normal | 5 | 5 | 1 | 4 | 0.180 | 0.999 |
High | 14 | 14 | 18 | 15 |
SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HR: heart rate; BMI: body mass index; BFP: body fat percentage. BFP: normal ≤29.9; high ≥30.
χ 2 test: ∗p<0.05.